Mesa Biotech Pandemic Pushes Handheld qPCR Devices Closer to Commercialization Premium Miniaturized sample-to-answer devices in development hint at an evolving molecular diagnostics landscape but launch timelines for these platforms remain unclear. FDA Posts Info on Impact of SARS-CoV-2 Mutations on Test Effectiveness The FDA identified molecular tests from Mesa Biotech, Applied DNA Sciences, Thermo Fisher Scientific, and Cepheid that could be affected by certain mutations. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M The firm sells a rapid, point-of-care, PCR platform for infectious disease diagnostics, including SARS-CoV-2, influenza, respiratory syncytial virus, and strep A. FDA Issues Alert About Potential False Negative Test Results From SARS-CoV-2 Mutations The agency identified three tests potentially impacted by known mutations, and said it will continue to monitor authorized assays. Mesa Biotech Receives 510(k) Clearance, CLIA Waiver for Strep A Molecular Point-of-Care Test The firm said its test fits in the palm of a hand and delivers results in 30 minutes by detecting bacterial nucleic acid in throat, nasal, or nasopharyngeal swabs. Nov 6, 2020 Mesa Biotech Awarded $13M in BARDA Funding for Coronavirus, Flu Combo Test Jul 31, 2020 NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics Apr 24, 2020 People in the News: Megan Bailey, Maureen Cronin, Ronald Park, Ingo Chakravarty, More Apr 1, 2020 Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve Mar 24, 2020 Mesa Biotech COVID-19 Test Receives FDA Emergency Use Authorization Mar 18, 2020 Mesa Biotech Point-of-Care Coronavirus Test Development Receives $561,330 From BARDA Mar 12, 2020 Mesa Biotech Prepping Handheld Coronavirus Molecular Diagnostic System for EUA Premium Aug 5, 2019 Molecular Testing for Flu Catching up, But Still Lags Far Behind Use of Rapid Immunoassays Premium Nov 27, 2018 Mesa Biotech Respiratory Tract Infection Test Gets FDA Clearance, CLIA Waiver Nov 13, 2018 Mesa Biotech RSV Test Wins CE Mark Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.